The Tipper-Strominger Hypothesis and Triggering of Allostery in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus (MRSA)
- PMID: 25964995
- PMCID: PMC4686766
- DOI: 10.1021/jacs.5b01374
The Tipper-Strominger Hypothesis and Triggering of Allostery in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus (MRSA)
Abstract
The transpeptidases involved in the synthesis of the bacterial cell wall (also known as penicillin-binding proteins, PBPs) have evolved to bind the acyl-D-Ala-D-Ala segment of the stem peptide of the nascent peptidoglycan for the physiologically important cross-linking of the cell wall. The Tipper-Strominger hypothesis stipulates that β-lactam antibiotics mimic the acyl-D-Ala-D-Ala moiety of the stem and, thus, are recognized by the PBPs with bactericidal consequences. We document that this mimicry exists also at the allosteric site of PBP2a of methicillin-resistant Staphylococcus aureus (MRSA). Interactions of different classes of β-lactam antibiotics, as mimics of the acyl-D-Ala-D-Ala moiety at the allosteric site, lead to a conformational change, across a distance of 60 Å to the active site. We directly visualize this change using an environmentally sensitive fluorescent probe affixed to the protein loops that frame the active site. This conformational mobility, documented in real time, allows antibiotic access to the active site of PBP2a. Furthermore, we document that this allosteric trigger enables synergy between two different β-lactam antibiotics, wherein occupancy at the allosteric site by one facilitates occupancy by a second at the transpeptidase catalytic site, thus lowering the minimal-inhibitory concentration. This synergy has important implications for the mitigation of facile emergence of resistance to these antibiotics by MRSA.
Figures



Similar articles
-
The Allosteric Site for the Nascent Cell Wall in Penicillin-Binding Protein 2a: An Achilles' Heel of Methicillin-Resistant Staphylococcus aureus.Curr Med Chem. 2015;22(14):1678-86. doi: 10.2174/0929867322666150311150215. Curr Med Chem. 2015. PMID: 25760091 Free PMC article. Review.
-
Penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus.IUBMB Life. 2014 Aug;66(8):572-7. doi: 10.1002/iub.1289. Epub 2014 Jul 14. IUBMB Life. 2014. PMID: 25044998 Free PMC article. Review.
-
Conformational Dynamics in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus, Allosteric Communication Network and Enablement of Catalysis.J Am Chem Soc. 2017 Feb 8;139(5):2102-2110. doi: 10.1021/jacs.6b12565. Epub 2017 Jan 27. J Am Chem Soc. 2017. PMID: 28099001 Free PMC article.
-
How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function.Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):16808-13. doi: 10.1073/pnas.1300118110. Epub 2013 Oct 1. Proc Natl Acad Sci U S A. 2013. PMID: 24085846 Free PMC article.
-
Targeting MRSA penicillin-binding protein 2a: structural insights, allosteric mechanisms, and the potential of adjuvant inhibitors.Biochem Pharmacol. 2025 Sep;239:117048. doi: 10.1016/j.bcp.2025.117048. Epub 2025 Jun 6. Biochem Pharmacol. 2025. PMID: 40484039 Review.
Cited by
-
Exploration of the Structural Space in 4(3H)-Quinazolinone Antibacterials.J Med Chem. 2020 May 28;63(10):5287-5296. doi: 10.1021/acs.jmedchem.0c00153. Epub 2020 May 8. J Med Chem. 2020. PMID: 32343145 Free PMC article.
-
Peptidoglycan Cross-Linking Preferences of Staphylococcus aureus Penicillin-Binding Proteins Have Implications for Treating MRSA Infections.J Am Chem Soc. 2017 Jul 26;139(29):9791-9794. doi: 10.1021/jacs.7b04881. Epub 2017 Jul 11. J Am Chem Soc. 2017. PMID: 28691491 Free PMC article.
-
β-Lactamases: A Focus on Current Challenges.Cold Spring Harb Perspect Med. 2017 Jan 3;7(1):a025239. doi: 10.1101/cshperspect.a025239. Cold Spring Harb Perspect Med. 2017. PMID: 27742735 Free PMC article. Review.
-
Antimicrobial activity of ceftaroline against methicillin-resistant Staphylococcus aureus (MRSA) isolates collected in 2013-2014 at the Geneva University Hospitals.Eur J Clin Microbiol Infect Dis. 2017 Feb;36(2):343-350. doi: 10.1007/s10096-016-2807-5. Epub 2016 Oct 15. Eur J Clin Microbiol Infect Dis. 2017. PMID: 27744604 Free PMC article.
-
β-Lactam Resistance Mechanisms: Gram-Positive Bacteria and Mycobacterium tuberculosis.Cold Spring Harb Perspect Med. 2016 May 2;6(5):a025221. doi: 10.1101/cshperspect.a025221. Cold Spring Harb Perspect Med. 2016. PMID: 27091943 Free PMC article. Review.
References
-
- Leemans E, Fisher J, Mobashery S. The β-Lactam Antibiotics: Their Future in the Face of Resistance. In: Marinelli F, Genilloud O, editors. Antimicrobials. Springer Berlin Heidelberg: 2014. pp. 59–84.
-
- Jevons MP. BMJ. 1961;1(5219):124–125.
-
- Fuda C, Suvorov M, Vakulenko SB, Mobashery S. J. Biol. Chem. 2004;279(39):40802–40806. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical